{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:36:45Z","timestamp":1793137005059,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaad.2025.06.038","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:39:33Z","timestamp":1750333173000},"page":"1301-1310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mastocytosis: Part II: Diagnosis and management of mastocytosis through a multidisciplinary lens"],"prefix":"10.1016","volume":"95","author":[{"given":"Caitlin A.","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Petty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alexander","family":"Sizemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.M.","family":"Rein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan O.","family":"Jamison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-0529","authenticated-orcid":false,"given":"Matilda W.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.038_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2340\/00015555-2210","article-title":"Diagnosis of mastocytosis in children and adults in daily clinical practice","volume":"96","author":"Lange","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.038_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaad.2025.06.038_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.038_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.038_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0889-8588(05)70295-1","article-title":"Mastocytosis and the skin","volume":"14","author":"Soter","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.038_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11588890-000000000-00000","article-title":"Diagnosis and treatment of cutaneous mastocytosis in children","volume":"12","author":"Castells","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.038_bib8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ajh.26966","article-title":"The international consensus classification of eosinophilic disorders and systemic mastocytosis","volume":"98","author":"Wang","year":"2023","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.038_bib9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1468-3083.2011.04350.x","article-title":"Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature","volume":"26","author":"Lange","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.038_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","article-title":"Diagnostic criteria and classification of mastocytosis in 2014","volume":"34","author":"Akin","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.038_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.038_bib12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis","volume":"136","author":"Carter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.038_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM199202273260912","article-title":"Systemic mastocytosis","volume":"326","author":"Austen","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.06.038_bib14","first-page":"185","article-title":"Regulation of normal and neoplastic human mast cell development in mastocytosis","volume":"116","author":"Metcalfe","year":"2005","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.038_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/ard.2004.029116","article-title":"Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment","volume":"64","author":"Lim","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajd.13443","article-title":"Cutaneous mastocytosis: a dermatological perspective","volume":"62","author":"Di Raimondo","year":"2021","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00428-022-03423-3","article-title":"The international consensus classification of mastocytosis and related entities","volume":"482","author":"Leguit","year":"2023","journal-title":"Virchows Arch"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.038_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/DAD.0000000000002474","article-title":"Cutaneous lesions of mastocytosis: mast cell count, morphology, and immunomolecular phenotype","volume":"45","author":"Damman","year":"2023","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.038_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/his.14573","article-title":"Establishing diagnostic criteria for mastocytosis in skin biopsies","volume":"80","author":"Drabent","year":"2022","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib20","first-page":"29","article-title":"Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment","volume":"83","author":"Bunimovich","year":"2009","journal-title":"Cutis"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.038_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.038_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.038_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"HemaSphere"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.038_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib25","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2021.068","article-title":"Systemic mastocytosis: multidisciplinary approach","volume":"13","author":"Zanotti","year":"2021","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.038_bib26","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1182\/bloodadvances.2024012756","article-title":"Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM","volume":"8","author":"L\u00fcbke","year":"2024","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.038_bib27","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"\u00c1lvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.038_bib28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/all.12436","article-title":"Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis","volume":"69","author":"Valent","year":"2014","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.038_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.anai.2021.06.019","article-title":"Inherited and acquired determinants of serum tryptase levels in humans","volume":"127","author":"Lyons","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.038_bib30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.038_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.13567","article-title":"Paediatric mastocytosis: a systematic review of 1747 cases","volume":"172","author":"M\u00e9ni","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib32","first-page":"34","article-title":"Systemic mastocytosis: diagnosis and management in 2024","volume":"3","author":"Lee","year":"2024","journal-title":"Can Hematol Today"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib33","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2021.069","article-title":"Pediatric mastocytosis: an update","volume":"13","author":"Giona","year":"2021","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.038_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.038_bib35","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3324\/haematol.2018.195867","article-title":"Preclinical human models and emerging therapeutics for advanced systemic mastocytosis","volume":"103","author":"Arock","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.038_bib36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.iac.2023.04.008","article-title":"KIT mutations and other genetic defects in mastocytosis","volume":"43","author":"Chantran","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.038_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2017.277897","article-title":"Digital PCR: a sensitive and precise method for KIT D816V quantification in mastocytosis","volume":"64","author":"Greiner","year":"2018","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2018.1.127","article-title":"The new tool \u201cKIT\u201d in advanced systemic mastocytosis","volume":"2018","author":"Shomali","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"16","key":"10.1016\/j.jaad.2025.06.038_bib39","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2019000932","article-title":"New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis","volume":"135","author":"Reiter","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2025.06.038_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100693","article-title":"Non-hematologic diagnosis of systemic mastocytosis: collaboration of radiology and pathology","volume":"45","author":"Ozturk","year":"2021","journal-title":"Blood Rev"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.038_bib41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00256-012-1374-9","article-title":"Advanced imaging of skeletal manifestations of systemic mastocytosis","volume":"41","author":"Fritz","year":"2012","journal-title":"Skeletal Radiol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.038_bib42","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s00261-014-0334-3","article-title":"Gastrointestinal manifestations of systemic disease: a multimodality review","volume":"40","author":"Nay","year":"2015","journal-title":"Abdom Imaging"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.038_bib43","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.3390\/ijms20122976","article-title":"Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches","volume":"20","author":"Valent","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.038_bib44","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/ijd.14103","article-title":"Efficacy of PUVA in Russian patients with mastocytosis: a case series and review of literature","volume":"57","author":"Pyatilova","year":"2018","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.038_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.iac.2014.01.012","article-title":"Treatment strategies in mastocytosis","volume":"34","author":"Siebenhaar","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.038_bib46","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0091-6749(90)90067-E","article-title":"Cromolyn sodium in the management of systemic mastocytosis","volume":"85","author":"Horan","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2025.06.038_bib47","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.19463.1","article-title":"Recent advances in the understanding and therapeutic management of mastocytosis","volume":"8","author":"Rossignol","year":"2019","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.iac.2016.08.017","article-title":"Mastocytosis and anaphylaxis","volume":"37","author":"Schuch","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.038_bib49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.038_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-015-0525-1","article-title":"Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?","volume":"15","author":"Matito","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib51","first-page":"45","article-title":"Anaphylaxis and mast cell disorders","volume":"42","author":"G\u00fclen","year":"2022","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.jaad.2025.06.038_bib52","article-title":"Efficacy of Omalizumab in indolent systemic mastocytosis","volume":"2019","author":"Slapnicar","year":"2019","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.jaad.2025.06.038_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.819097","article-title":"Successful imatinib treatment for systemic mastocytosis associated with myelodysplastic\/myeloproliferative neoplasm: report of a case and literature review","volume":"11","author":"Barozzi","year":"2022","journal-title":"Front Oncol"},{"issue":"414","key":"10.1016\/j.jaad.2025.06.038_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao1690","article-title":"A precision therapy against cancers driven by KIT\/PDGFRA mutations","volume":"9","author":"Evans","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib55","article-title":"Avapritinib for cutaneous mastocytosis","volume":"101","author":"Lee","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.038_bib56","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajh.26962","article-title":"Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management","volume":"98","author":"Pardanani","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2025.06.038_bib57","series-title":"ASH","article-title":"Results from pioneer: a randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis","author":"Akin","year":"2020"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.038_bib58","first-page":"80","article-title":"Recent advances in the therapeutic management of advanced systemic mastocytosis","volume":"14","author":"Veitch","year":"2023","journal-title":"Diagn Basel Switz"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.038_bib59","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41591-021-01538-9","article-title":"Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial","volume":"27","author":"DeAngelo","year":"2021","journal-title":"Nat Med"},{"issue":"Suppl","key":"10.1016\/j.jaad.2025.06.038_bib60","article-title":"P1023: avapritinib in patients with advanced systemic mastocytosis (AdvSM): efficacy and safety analyses from the phase 2 pathfinder study with 2-year follow-up","volume":"7","author":"Gotlib","year":"2023","journal-title":"HemaSphere"},{"issue":"29","key":"10.1016\/j.jaad.2025.06.038_bib61","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1200\/JCO.2014.55.2018","article-title":"Hematopoietic stem-cell transplantation for advanced systemic mastocytosis","volume":"32","author":"Ustun","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.038_bib62","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaci.2015.05.034","article-title":"Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis","volume":"136","author":"Wiechers","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2025.06.038_bib63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.HS9.0000847064.38588.9b","article-title":"P1049: a phase 2 study of Bezuclastinib (Cgt9486), a novel, highly selective, potent kit D816v inhibitor, in adults with advanced systemic mastocytosis (apex): methods, baseline data, and early insights","volume":"6","author":"DeAngelo","year":"2022","journal-title":"HemaSphere"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.038_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11899-024-00737-8","article-title":"Systemic mastocytosis: state of the art","volume":"19","author":"Farmer","year":"2024","journal-title":"Curr Hematol Malig Rep"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.038_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2023.11.722","article-title":"Initial results from summit: an on-going, 3-part, multi-center, randomized, double-blind, placebo-controlled phase 2 clinical study of Bezuclastinib in adult patients with NonAdvanced systemic mastocytosis (NonAdvSM)","volume":"153","author":"Modena","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2025.06.038_bib66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood-2023-188904","article-title":"Elenestinib, an investigational, next generation KIT D816V inhibitor, reduces mast cell burden, improves symptoms, and has a favorable safety profile in patients with indolent systemic mastocytosis: analysis of the harbor trial","volume":"142","author":"Tashi","year":"2023","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.jaad.2025.06.038_bib67","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1182\/blood-2022-167410","article-title":"AZURE: a phase 1\/2 study of blu-263 as monotherapy and in combination with azacitidine in patients with advanced systemic mastocytosis","volume":"140","author":"DeAngelo","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.038_bib69","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bjd\/ljad191","article-title":"Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial","volume":"189","author":"Siebenhaar","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:30:32Z","timestamp":1793136632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225023655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0190962225023655"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.038","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mastocytosis: Part II: Diagnosis and management of mastocytosis through a multidisciplinary lens","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(26)03566-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}